RxDoctor Payments Data

Paul Miller, MD

Psychiatry · Maryville, TNNPI 1407820863

Payments from drug & device makers

$637in general payments, 2019–2025

Across 21 payments — averaging $30.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$304
  • Johnson & Johnson$81
  • Xeris Pharmaceuticals, Inc.$36
  • Astellas Pharma US Inc$31
  • Sage Therapeutics, LLC$31
  • Otsuka America Pharmaceutical, Inc.$28
  • plus $125 from 8 others

What the payments were for

  • Food & beverage$333100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$637 in reported general payments places this provider in the 60th percentile of 503 psychiatry providers in Tennessee.

See all psychiatry providers in Tennessee

Medicare billing

Part B allowed, 2024
$17,356
Medicare patients
82
Services billed
238

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl32$59,339
RexultiBrexpiprazole24$36,726
NuedextaDextromethorphan Hbr/Quinidine12$18,136
DepakoteDivalproex Sodium13$16,689
Lurasidone Hcl22$6,423
Vilazodone Hcl32$4,626
Medroxyprogesterone Acetate11$2,426
Divalproex Sodium ErDivalproex Sodium20$2,289
Clozapine12$1,883
Duloxetine Hcl64$1,679
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine15$1,599
Desvenlafaxine Succinate ErDesvenlafaxine Succinate19$1,565
Mirtazapine95$1,533
Quetiapine Fumarate99$1,525
Fluoxetine Hcl48$1,349

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$304$59,33932 claims
Otsuka America Pharmaceutical, Inc.Rexulti$28$36,72624 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 503 psychiatry providers in Tennessee.

Other psychiatry in Maryville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →